-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, K6EkMc0oKc+Ctj20b+szQaVQFVLpwrF1Iiw4taeOV8pJwKYhjHvq3ER8q0Kw6E5Q wwiRA0Iga+rxIxeBUXagag== 0001181152-07-000002.txt : 20070518 0001181152-07-000002.hdr.sgml : 20070518 20070518151442 ACCESSION NUMBER: 0001181152-07-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070516 FILED AS OF DATE: 20070518 DATE AS OF CHANGE: 20070518 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACEUTICAL PRODUCT DEVELOPMENT INC CENTRAL INDEX KEY: 0001003124 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 561640186 STATE OF INCORPORATION: NC FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 929 NORTH FRONT STREET CITY: WILMINGTON STATE: NC ZIP: 28401 BUSINESS PHONE: 9102510081 MAIL ADDRESS: STREET 1: 929 NORTH FRONT STREET CITY: WILMINGTON STATE: NC ZIP: 28401 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BONDURANT STUART CENTRAL INDEX KEY: 0001181152 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27570 FILM NUMBER: 07864526 BUSINESS ADDRESS: STREET 1: PHARMACEUTICAL PRODUCT DEVELOPMENT INC STREET 2: 3151 S 17TH ST CITY: WILMINGTON STATE: DE ZIP: 28412 BUSINESS PHONE: 9102510081 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2007-05-16 0001003124 PHARMACEUTICAL PRODUCT DEVELOPMENT INC PPDI 0001181152 BONDURANT STUART 205 UNIVERSITY DRIVE CHAPEL HILL NC 27514 1 0 0 0 Common Stock 11215 D Stock Options (to buy) 33.82 2007-05-16 4 A 0 6126 0 A 2007-05-16 2017-05-15 Common Stock 6126 6126 D Stock Options (to buy) 35.38 2006-05-17 2016-05-16 Common Stock 3973 3973 D Stock Options (to buy) 23.79 2005-05-18 2015-05-17 Common Stock 5458 5458 D Lisa C. Noecker attorney-in-fact for Stuart Bondurant 2007-05-18 -----END PRIVACY-ENHANCED MESSAGE-----